Charts Northwest Biotherapeutics, Inc.

Stocks

Market Closed - OTC Markets Other stock markets 20:59:53 04/06/2026 BST			5-day change	1st Jan Change
0.2050 ^USD	+0.49%		+21.52%	-10.40%

07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
05-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

ProRealTime Chart